Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.
about
The prognostic impact of high on-treatment platelet reactivity with aspirin or ADP receptor antagonists: systematic review and meta-analysisA meta-analysis of sex-related differences in outcomes after primary percutaneous intervention for ST-segment elevation myocardial infarction.Unfavourable risk factor control after coronary events in routine clinical practice.THE STORM (acute coronary Syndrome in paTients end Of life and Risk assesMent) study.Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy.Percutaneous pleural drainage in patients taking clopidogrel: real danger or phantom fear?
P2860
Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Discontinuation of dual antipl ...... atic review and meta-analysis.
@en
type
label
Discontinuation of dual antipl ...... atic review and meta-analysis.
@en
prefLabel
Discontinuation of dual antipl ...... atic review and meta-analysis.
@en
P2093
P2860
P50
P356
P1476
Discontinuation of dual antipl ...... matic review and meta-analysis
@en
P2093
Claudio Moretti
Fabrizio D'Ascenzo
Fiorenzo Gaita
Giuseppe Tarantini
James J Di Nicolantonio
Pierluigi Omedè
P2860
P304
P356
10.1111/JOIC.12107
P577
2014-03-14T00:00:00Z